Showing results (1001-1010 of 2,515) with videos related to

Sort By:
Pageof 252
Diabetes & Metabolic Syndrome|October 6, 2022
Diabetes in Pregnancy Study Group India (DIPSI) and WHO (1999) diagnostic criteria for GDM: A meta-analysisDimple Rawat, Rinchen Zangmo, Sumit Roy Chowdhury, et al.
Diabetes & Metabolic Syndrome|September 1, 2022
Effect of various exercise protocols on neuropathic pain in individuals with type 2 diabetes with peripheral neuropathy: A systematic review and meta-analysisSripada Pallavi Tatikola, Venkatesh Natarajan, Venkata Krishnaveni Desai, et al.
Diabetes & Metabolic Syndrome|October 7, 2021
Symptomatic post-vaccination SARS-CoV-2 infections in healthcare workers- A multicenter cohort studyRaju Vaishya, Anupam Sibal, Arpita Malani, et al.
Diabetes & Metabolic Syndrome|January 27, 2022
Prevalence and risk factors of lower limb amputations in patients with diabetic foot ulcers: A systematic review and meta-analysisBeverly T Rodrigues, Venkat N Vangaveti, Ravindra Urkude, et al.
Diabetes & Metabolic Syndrome|February 19, 2022
Could high heat cooking and food processing promoting neo-formed contaminants partially explain the high prevalence of chronic kidney disease in South Asian populations? A hypothesisPrerna Krishan, Raj S Bhopal, Antonis Vlassopoulos, et al.
Diabetes & Metabolic Syndrome|February 26, 2022
Prevalence and associated factors of underweight and overweight/obesity among reproductive-aged women: A pooled analysis of data from South Asian countries (Bangladesh, Maldives, Nepal and Pakistan)Farzana Ferdausi, Md Akib Al-Zubayer, Syed Afroz Keramat, et al.
Diabetes & Metabolic Syndrome|September 25, 2021
No adverse effects of dairy products on lipid profile: A systematic review and meta-analysis of randomized controlled clinical trialsSeyedeh-Masomeh Derakhshandeh-Rishehri, Saeed Ghobadi, Masoumeh Akhlaghi, et al.
Diabetes & Metabolic Syndrome|September 25, 2021
Do SGLT-2 inhibitors exhibit similar cardiovascular benefit in patients having reduced ejection fraction heart failure with type 2 diabetes, prediabetes and normoglycemia?Awadhesh Kumar Singh, Ritu Singh
Diabetes & Metabolic Syndrome|October 30, 2021
COVID-19 associated mucormycosis: A Descriptive Multisite Study from IndiaRitesh Gupta, Jothydev Kesavadev, Gopika Krishnan, et al.
Diabetes & Metabolic Syndrome|February 5, 2022
Empagliflozin improves quality of life in nondiabetic HFrEF patients. Sub-analysis of the EMPATROPISM trialJuan Antonio Requena-Ibáñez, Carlos García Santos-Gallego, Anderly Rodriguez-Cordero, et al.
Pageof 252